INTRODUCTION
The Bromeliaceae, one of the largest botanical families of the New World, is distributed extensively in tropical America [1] . This family comprises 58 genera and 3172 species [2] . Considering the large number of species of the Bromeliaceae family, few have been studied chemically so far. Despite this, there is a considerable amount of identified compounds, which mostly belong to the class of triterpenoids and flavonoids. Other classes of compounds such as sterols, diterpenes, cinnamic acids, lignans, nitrogen compounds, amongst others, were also identified [3] . Some studies have demonstrated that species of the Bromeliaceae family have pharmacological properties such as antioedematogenic and free radical scavenging [4] , antinociceptive and anti-inflammatory [5] , anti-allergic [6] , antiulcer [7] , cytotoxic [8] , antioxidant and antimycobacterial activities [9] .
Bromelia is one of the most diverse genera within Bromeliaceae and includes 56 species [2] . Some species of this genus are used in traditional medicine as a vermifuge, anti-helmintic, diuretic, in cases of respiratory and kidney problems, intestinal disorders, diabetes, amongst others [10] . Bromelia antiacantha is one of the most studied species [11] . Bromelia laciniosa is a species native to the Brazilian Caatinga which is known in the Northeast region of Brazil as "macambira" and is used in the alimentation of man and domestic animals, especially in times of drought [12] . From the base of the leaves is extracted a mass, that produces a type of bread [13] . The main therapeutic indications are for treating child colic, diarrhea, fever, jaundice, dandruff and hepatitis [14] . The decoction of the roots is also popularly used against hepatitis and intestinal disorders, as a diuretic, while the dried and powdered leaves are used in cooking as a source of protein [3, 10] .
Considering the popular use and because of the scarcity of pharmacological studies about this species, this study evaluated the antinociceptive activity as well as the acute toxicity of the ethanolic extract from leaves of Bromelia laciniosa in mice.
EXPERIMENTAL

Plant material
The leaves of Bromelia laciniosa Mart. ex Schult. f. were collected in the city of Petrolina, State of Pernambuco, Brazil, in January of 2011 (Coordinates 08°59'16.90" S and 40°35'20.60" W). A voucher specimen (no. 6442) was deposited at the Herbarium Vale do São Francisco (HVASF) of the Universidade Federal do Vale do São Francisco.
Preparation of extracts
The leaves of B. laciniosa dried and pulverized (879 g) were subjected to maceration with 95 % EtOH for 72 h. The solution was filtered and concentrated in a rotatory evaporator oven at 50 oC, producing 39 g of crude ethanol extract (BlEtOH).
Analysis of Bl-EtOH by high performance liquid chromatography (HPLC)
The solvents used in high performance liquid chromatography are of analytical grade from Merck®. A Milli-Q System® (Bedford, MA, USA) was used to purify the water. Analysis using high performance liquid chromatography was performed on a Merck-Hitachi liquid chromatograph LaChrom Elite® equipped with a VRW HITACHI L-2130 pump, a VRW HITACHI L-2300 Diode-Array Detector (DAD), and an auto sampler with a 100 μl loop. The data was acquired and processed using Ezchrom Elite software. The extract was analyzed using a reverse-phase HPLC column: Purospher® STAR RP-18e (250 mm × 4.6 mm i.d., 5 µm) column (Merck). The mobile phase was composed of solvent (A) H 2 O/H 3 PO 4 0.1 % and solvent (B) MeOH. The solvent gradient was composed of A (75 -0 %) and B (25 -100 %) for 20 min, then 100 % B for 4 min, then again at the initial conditions (75 % A and 25 % B) for 10 min. A flow rate of 1.0 ml/min was used in a 30 ºC oven, and 20 μl of each sample was injected. The procedure was repeated three times for each sample. Samples and mobile phases were filtered through a 0.22 μm Millipore filter prior to HPLC injection. Spectra data were recorded from to 200 to 400 nm during the entire run.
Animals
Male and female adult albino Swiss mice (25 -35 g) were used throughout this study. The animals were randomly housed in appropriate cages at 22 ± 2 °C on a 12 h light/dark cycle (lights on at 6:00 a.m.) with free access to food and water. When necessary, animals were deprived of food 12 h prior to the experiments. Experimental protocols and procedures were approved by the Federal University of Vale do São Francisco Animal Care and Use Committee by number 21051023.
Acetic acid-induced writhing test in mice
This test was performed as described by Koster et al [15] . Mice (n = 6) were intraperitoneally pretreated 30 min before the nociceptive agent, acetic acid 0.9 % (v/v, 10 ml/kg). Vehicle (saline), Bl-EtOH (100, 200 and 400 mg/kg, body weight), acetylsalicylic acid (ASA, 200 mg/kg) and morphine (10 mg/kg) were administered before acetic acid injection. Following the injection of acetic acid, the intensity of nociceptive behavior was quantified by counting the total number of writhes (a response consisting of contraction of the abdominal wall, pelvic rotation followed by hind limb extension) occurring between 5 and 15 min after stimulus injection [16] .
Formalin test
Twenty microlitres of 2.5 % formalin was injected subcutaneously into the right hind paw of mice.
The time (in seconds) spent in licking and biting responses of the injected paw was taken as an indicator of pain response. Responses were measured for 5 min after formalin injection (first phase, neurogenic phase) and 15-30 min after formalin injection (second phase, inflammatory phase). Bl-EtOH (100, 200 and 400 mg/kg), ASA (200 mg/kg) and morphine (10 mg/kg) were administered intraperitoneally 60 min before formalin injection. Control animals received the same volume of saline. Mice were observed in the chambers with a mirror mounted on three sides to allow view of the paws [17] .
Hot plate test
Mice were pre-selected on the hot plate at 55 ± 0.5 o C. Licks on the rear paws were the parameters of observation. Animals showing a reaction time (latency for licking the hind feet or jumping) greater than 20 s were discarded. The animals were then treated with vehicle (saline, 0.1 ml/10 g), morphine (10 mg/kg) and Bl-EtOH (100, 200 and 400 mg/kg) intraperitoneally. Latency time (in seconds) for each mouse was determined on the hot plate during the maximum period of 20 s, at intervals of 30, 60, 90 and 120 min after the administration of the extract [18] .
Acute toxicity
Animals were randomly divided in groups of five male and five female Swiss mice (n=10). Animals were administered 2.0 g/kg intraperitoneally and 5.0 g/kg orally of the crude ethanol extract of Bromelia laciniosa. Control group received vehicle. Subsequently, the animals were observed for 14 days to evaluate the presence of signs of toxicity. Mortality in each group within 72 h was recorded. LD 50 was estimated by the method described by Litchfield & Wilcoxon [19] . The mice were assessed daily throughout the study to monitor their body weight variation, consumption of food and water.
Analysis of hematological and biochemical parameters
For the evaluation of hematological and biochemical parameters of blood was evaluated using the method described by Vasconcelos et al [20] . Blood was removed after 14 days through brachial plexus for laboratory analysis of hematological parameters: count of erythrocytes, hemoglobin, hematocrit, the mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), the mean corpuscular hemoglobin concentration (MCHC), leukocytes, lymphocytes and platelets. The biochemical parameters analyzed in serum samples were triglycerides, AST/TGO, ALT/TGP, urea and creatinine.
For the determination of hematological parameters, hematology analyser Sysmex XT-2000 was used. For the determination of biochemical parameters, an automatic analyser Wiener BT 3000 Plus was used.
Statistical analysis
The data obtained were analyzed using the GraphPad Prism® version 4.0 and expressed as mean ± SEM. Statistically significant differences between groups were calculated by the application of analysis of variance (ANOVA) followed by Dunnett's test. Values were considered statistically significant at p < 0.05.
RESULTS
Phytochemical profile of extract
Phenolic profiles at 320 nm for the Bl-EtOH evaluated are presented in Figure 1 
Analgesic activity of extract
Bl-EtOH had analgesic effects on both the first (0 -5) and second phase (15 -30) of formalininduced pain. These phases correspond to neurogenic and inflammatory pains, respectively. Bl-EtOH (100, 200 and 400 mg/kg, i.p.) decreased by 60.86, 62.84 and 66.79 %, respectively, the paw licking time in the first phase, as well as 91.93, 82.18 and 88.73 %, respectively, in the second phase of the formalin test (Figure 3 ). The treatment with acetylsalicylic acid and morphine was also able to inhibit the first and second phases. The pre-treatment with naloxone (1.5 mg/kg, i.p.) reversed the antinociceptive activity of the extract at dose of 100 mg/kg in the first phase of this test. The effect of morphine (10 mg/kg) was also reversed by naloxone. Figure 4 shows the results of the hot plate test. The reaction time parameter was only significantly increased at a dose of 100 mg/kg in 60 min. The effect of morphine was reversed by naloxone.
Opioid antinociceptive activity
Acute toxicity
In the acute toxicity of Bl-EtOH, behavioral and physiological alterations were not observed. No animals died from the 2.0 g/kg intraperitoneally and 5.0 g/kg orally, respectively, indicating low toxicity of the extract. The administration of the extract did not cause any appreciable alterations in water and food intake in any of the groups. Moreover, body weight gain during the observation period among the treated animals with 5 g/kg v.o. was statistically different when comparable to control group ( Figure 5 ).
Hematological and biochemical profiles
The administration of intraperitoneal and oral doses of Bl-EtOH did not cause erythrocytes, hemoglobin, hematocrit, MCV, MCH, MCHC, leukocytes, lymphocytes and platelets level to change (Table 1) . Likewise, the values of triglycerides, AST/GOT, ALT/GPT and urea (mg/dl) showed no significant changes. However, a significant decrease in the creatinine in the group treated with 5 g/kg by oral route was observed when compared to the control group (Table 2) .
DISCUSSION
The present study shows that the ethanolic extract of Bromelia laciniosa has phenolic compounds, which are possibly responsible for their antinociceptive properties. A HPLC fingerprint of phenolic compounds was developed and showed the presence of characteristic peaks for these compounds.
The first test to evaluate the antinociceptive activity of Bl-EtOH was the writhing induced by acetic acid. Acetic acid-induced writhing is a standard, simple, and sensitive test for measuring analgesia induced by both opioids and peripherally acting analgesics. Additionally, although this test is a nonspecific model, it is widely used for analgesic screening and involves local peritoneal receptors [21] . Bl-EtOH significantly reduced the acetic acid-induced writhing in mice. These results support the hypothesis of Bl-EtOH participation in the inhibition of prostaglandin synthesis, as the nociceptive mechanism involves the process or release of arachidonic acid metabolites via cyclooxygenase (COX), prostaglandin biosynthesis or other peripheral pathway [22] . A positive result with this test is indicative of antinociceptive activity in the extract under investigation, which may be of central or peripheral origin.
In order to distinguish between the central and peripheral antinociceptive action, the formalin test was performed. Subcutaneous injection of formalin into the animal hind paw evokes an array of stereotyped behaviors. The nociceptive response to formalin occurs in a biphasic pattern; there is an initial acute period (phase 1) and, after a short period of remission, phase 2 begins and consists of a longer period of sustained activity. The phase 1 corresponds to acute nociceptive neurogenic pain, and is sensitive to analgesic drugs that interact with opioid system. The phase 2 corresponds to an inflammatory pain, dependent on several inflammatory mediators release and action, and the expression of nociceptive behavior in this phase is very sensitive to non-steroid anti-inflammatory drugs as the cyclooxygenase inhibitors. Drugs that act primarily as central analgesics inhibit both phases while peripherally acting drugs inhibit only the second phase [23] . The extract was able to block both phases of the formalin response although the effect was more pronounced in the second phase. The effect of extract on the first and second phases of formalin test suggests that its activity may be resulted from its central action when compared with morphine activity in this respect. The pre-treatment with naloxone reversed the antinociceptive activity of the extract in the first phase of this test. The results suggest a possible involvement of opioid receptors in the antinociceptive effect of the extract. In this study, acetylsalicylic acid and morphine was also able to inhibit both phases of the formalin test. Previous study showed that acetylsalycilic acid and paracetamol to have actions independent of their inhibition of prostaglandin synthesis and they also have effects on non-inflammatory pain [24] , which was observed in this study for the AAS.
The evaluation of Bl-EtOH on hot plate response showed that the extract increases the latency time only at dose of 100 mg/kg after 60 min. As the hot plate test is a specific central antinociceptive test, it is possible that Bl-EtOH exert their antinociceptive effect at least in part through central mechanisms, as observed in the formalin test by inhibition of both phases of the test.
The use of medicinal plants has been very significant in several populations, especially in the Northeast of Brazil. However, the popular or traditional uses are not sufficient to validate the herbal medicines as effective and safe. It is necessary to carry out toxicological studies to evaluate safety parameters which are not observed in the popular use of these plants [25] .
The tests for acute toxicity of Bl-EtOH did not demonstrate signs of lethality in mice at doses tested. A 2.0 and 5.0 g/kg body weight administered by via intraperitoneal and oral, respectively, dose were considered as the "limit test", as recommended by acute toxicity testing procedures [20] . In the acute toxicity of Bl-EtOH, behavioral and physiological alterations were not observed and no animal died in the doses of 2.0 g/kg intraperitoneally and 5.0 g/kg orally, respectively, indicating low toxicity of the extract. In this experiment was observed that the BlEtOH has LD 50 > 5000 mg/kg. According to Kennedy et al [26] substances that present LD 50 higher than 5.0 g/kg by oral route can be considered practically non-toxic.
There was no significant variation in hematological parameters in the groups treated with the extract compared to control. In regard to biochemical parameters a significant decrease in the creatinine in the group treated with 5 g/kg by oral rout was observed when compared to the control group. Creatinine is a good indicator of kidney function. Alterations in their levels suggest alterations in this organ. Histopathological analysis of the kidneys revealed that the histological structure of renal tubules were preserved (data not shown).
CONCLUSION
The present work indicates that Bromelia laciniosa is a source of phenolic compounds and exhibit antinociceptive properties. Peripheral and, at least in part, central mechanisms may be involved in the antinociceptive effect. Further studies currently in progress will throw more light on the mechanisms of action underlying the effects observed in this investigation. The results obtained so far show that the plant is non-toxic at the doses used.
